Baxter International Inc. (BAX)

Market Cap	15.38B
Revenue (ttm)	10.77B
Net Income (ttm)	-560.00M
Shares Out	512.97M
EPS (ttm)	-1.10
PE Ratio	n/a
Forward PE	11.71
Dividend	$0.68 (2.27%)
Ex-Dividend Date	May 30, 2025

Volume	5,595,997
Open	29.93
Previous Close	29.80
Day's Range	29.78 - 30.19
52-Week Range	26.25 - 40.49
Beta	0.61
Analysts	Buy
Price Target	37.25 (+24.21%)
Earnings Date	Aug 5, 2025

About BAX

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technolog...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1931
• Employees: 60,000
• Stock Exchange: NYSE
• Ticker Symbol: BAX
• Website: https://www.baxter.com

Analyst Forecast

According to 8 analysts, the average rating for BAX stock is "Buy." The 12-month stock price forecast is $37.25, which is an increase of 24.21% from the latest price.

Price Target

$37.25

(24.21% upside)

Analyst Consensus: Buy